INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/09/2026
Back to search
Official data from USPTO
ONCOSNIPE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOSNIPE
ST13
US500000079214005Class
9, 42, 44
Filing
79214005
Registration
5516066
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/10/2026
Trademark type
Word
Nice classes
9, 42, 44
Filing date
12/23/2016
Registration date
07/17/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2025
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
FR
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
O. S. (pessoa física)
ONCODESIGN PRECISION MEDICINE (OPM)
ONCODESIGN, Société Anonyme à Conseil d'Administration
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable software for use in patient stratificationidentification of patients resistant to cancer treatmentsidentification of therapeutic targetsidentification of biomarkers; downloadable software for use in cancer diagnosticfor use with cancer treatment
Class 42
Scientific research; software as a service (SaaS) featuring software use in patient stratificationidentification of patients having resistance to cancer treatmentidentification of therapeutic targetsidentification of biomarkers; computer software development; technical project studiesconducting feasibility studiestechnical research in the field of cancer research and in the field of identification of patients having resistance to anticancer treatment
Class 44
Medical analysis for providing cancer treatmentproviding medical services in the nature of medical identification of patients resistance to treatments; medical care and identification and analysis services in the nature of medical diagnosis of cancerall relating to patient treatment
Publications
History of USPTO decisions and trademark events.
40 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/22/2026
INPC
INVALIDATION PROCESSED
03/22/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/30/2025
C71T
CANCELLED SECTION 71
01/31/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/16/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/16/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/16/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/17/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/30/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
10/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/17/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/01/2018
PUBO
PUBLISHED FOR OPPOSITION
05/01/2018
GPNX
NOTIFICATION PROCESSED BY IB
04/27/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/11/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/11/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/28/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
03/28/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/28/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
03/28/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/28/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2018
ALIE
ASSIGNED TO LIE
03/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/21/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/21/2018
RFNT
REFUSAL PROCESSED BY IB
09/09/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/23/2017
RFRR
REFUSAL PROCESSED BY MPU
08/23/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/20/2017
CNRT
NON-FINAL ACTION WRITTEN
08/19/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/19/2017
DOCK
ASSIGNED TO EXAMINER
08/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2017
Continuous trademark protection
Get notified about every new filing that threatens ONCOSNIPE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.